SCHEMBL8105590

SCHEMBL8105590

CC#CCc1nc(CC#CC)n(Cc2ccc(Cc3cccc(C(=O)O)c3)cc2)n1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
ROCK1 Q13464 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HTT P42858 2/20 0.38
POLB P06746 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
YTHDC1 Q96MU7 1/20 0.37
MYC P01106 1/20 0.36
PLA2G2A P14555 1/20 0.36
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
PTGER4 P35408 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8111250 0.88 PPARG (0.47) SMN1; SMN2NPC1RAB9AHDAC6
SCHEMBL8095759 0.85 CA1 (0.35) CA1CA2CA9SMN1; SMN2HTT
SCHEMBL8111000 0.82 TSHR (0.44) CA1CA2CA9
SCHEMBL8105656 0.80 PPARG (0.47) CA1CA2CA9SMN1; SMN2HTT
SCHEMBL8103529 0.79 AGTR1 (0.44) CA1CA2CA9ROCK1SMN1; SMN2
SCHEMBL8104901 0.78 AGTR1 (0.48)
SCHEMBL8105272 0.78 AGTR1 (0.46)
SCHEMBL8095785 0.78 CA1 (0.39) CA1CA2CA9ROCK1SMN1; SMN2
SCHEMBL8111078 0.78 CA1 (0.42) CA1CA2CA9ROCK1SMN1; SMN2
SCHEMBL8103172 0.78 AGTR1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3098772-B2 2000-10-16 JP claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP claimed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed